CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Schrödinger and BMS expand partnership to deploy AI for drug discovery

PartnershipPositive
AI Analysis

Summary

Schrödinger has entered a strategic agreement with Bristol Myers Squibb to integrate its AI-based co-scientist platform Bunsen into BMS's research operations.

Importance:6/10
Sentiment:
0.60
partnershipAIdrug discoverycollaboration
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 6, 2026 9:01 AM

Read Original